What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2026-06-08 compared with 2026-04-22 · 25 added, 25 removed, 88 unchanged (36% of the section changed)

7 unchanged sentences

OTC Bulletin Board and OTC Link quote our stock under FDCT.

The OTC Bulletin Board differs from

national and regional stock exchanges in that it:

(i) is not situated in a single location but operates through the communication of

bids, offers, and confirmations between broker-dealers and (ii) securities admitted to the quotation are offered by one or more broker-dealers

rather than the “specialist” common to stock exchanges.

The OTC Bulletin Board differs from national

and regional stock exchanges in that it:

(i) is not situated in a single location but operates through the communication of bids, offers,

and confirmations between broker-dealers and (ii) securities admitted to the quotation are offered by one or more broker-dealers rather

than the “specialist” common to stock exchanges.

Stock Performance:

9 unchanged sentences

indicates that as of December 31, 2025, we had 199 record holders of our Common Stock.

As of April 22, 2026, we had 423,084,729 shares

As of June 8, 2026, we had 423,084,729 shares

of our Common Stock, 4,500,000 shares of Series A Preferred Stock, and 2,371,844 shares of Series B Preferred Stock, and issued and outstanding.

3 unchanged sentences

Stock is non-dilutive and is not subject to stock splits or any other adjustments to the Company’s common stock.

Each share of Series

B Preferred Stock can be converted into 100 shares of the Company’s common stock at any time by the holder of such shares.

B Preferred Stock is entitled to one (1) vote per share on all matters presented to stockholders for action.

Each share of

Series B Preferred Stock can be converted into 100 shares of the Company’s common stock at any time by the holder of such shares.

Series B Preferred Stock is entitled to one (1) vote per share on all matters presented to stockholders for action.

Company did not declare any cash dividends for the December 31, 2025, fiscal year.

The Company’s Board of Directors, composed

of Mitchell Eaglstein, Imran Firoz, Jonathan Baumgart, and Gope S.

Kundnani, has determined that it does not anticipate declaring or

distributing cash dividends in the foreseeable future.

The Board of Directors decides the declaration, payment, timing, and amount

or number of future dividends.

The dividends will depend upon, among other things, the results of our operations, cash flows,

financial condition, operating and capital requirements, and other factors the Board of Directors considers relevant.

assurance that the Company will pay any future dividends.

If the Company decides to pay dividends, there is no assurance concerning

The Company’s Board of Directors, composed of

Mitchell Eaglstein, Imran Firoz, Jonathan Baumgart, and Gope S.

Kundnani, has determined that it does not anticipate declaring or distributing

cash dividends in the foreseeable future.

The Board of Directors decides the declaration, payment, timing, and amount or number of future

The dividends will depend upon, among other things, the results of our operations, cash flows, financial condition, operating

and capital requirements, and other factors the Board of Directors considers relevant.

There is no assurance that the Company will pay

any future dividends.

If the Company decides to pay dividends, there is no assurance concerning dividends.

Authorized for Issuance under Equity Compensation Plans

17 unchanged sentences

The original Certificate of Designation for the

Series B Convertible Preferred Stock, filed on December 4, 2023, designated 3,000,000 shares of our preferred stock, par value $0.0001 per

share, as Series B Convertible Preferred Stock.

The Series B Amendment did not change the number of authorized or issued shares of Series

B Convertible Preferred Stock or any of the other rights, preferences, or privileges of the Series B Convertible Preferred Stock, except

with respect to its conversion rights.

Series B Convertible Preferred Stock, filed on December 4, 2023, designated 3,000,000 shares of our preferred stock, par value $0.0001

per share, as Series B Convertible Preferred Stock.

The Series B Amendment did not change the number of authorized or issued shares of

Series B Convertible Preferred Stock or any of the other rights, preferences, or privileges of the Series B Convertible Preferred Stock,

except with respect to its conversion rights.

Series B Amendment deleted and replaced Section 4(a) (Conversion Right) in its entirety.

37 unchanged sentences

effective date.

of December 31, 2025, the Company has a 2023 Stock Incentive Plan.

December 31, 2025, the Company has a 2023 Stock Incentive Plan.

Sales of Unregistered Securities

4 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K/A

Item 5. Market for Registrant’s Common Equity